Showing results (61-70 of 65) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Health Policy (Amsterdam, Netherlands)|March 8, 2014
Regional tenders on biosimilars in Italy: an empirical analysis of awarded pricesSandro Curto, Simone Ghislandi, Katelijne van de Vooren, et al.Epidemiologia E Psichiatria Sociale|August 10, 2004
Health status, resource consumption, and costs of dysthymic patients in Italian primary careCorrado Barbui, Livio Garattini, Iva Krulichova, et al.Journal of Medical Economics|May 20, 2009
Cost minimisation analysis of 12 or 24 weeks of peginterferon alfa-2b + ribavirin for hepatitis C virusPaola De Compadri, Daniela Koleva, Alessandra Mangia, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 13, 2021
Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against CancerEduard Vrdoljak, Mario Sekerija, Stjepko Plestina, et al.Pharmacoeconomics|August 1, 2020
Integrative Review of Managed Entry Agreements: Chances and LimitationsCarolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, et al.Pageof 7